APLS- Apellis Pharmaceuticals, Inc.
Apellis Pharmaceuticals, Inc. (APLS) has 17 insiders with recent SEC Form 4 filings, including 0 buys and 11 sells. APLS is classified in the Biotechnology industry within the Health Care sector.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 1.18M | $48.30M | - | |
| CEO | 482.0K | $19.78M | - | |
| Dir | 385.0K | $15.80M | - | |
| Dir | 161.6K | $6.63M | - | |
| CFO | 152.0K | $6.24M | - |
Activity
Buys and sells only
Transactions
10 filings · page 2
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 17, 2025 | Watson David O.70 | General Counsel | Sell | 5,000 | $20.06 | $100,300.00 | -4.4% | +7.3% | - | |
| Oct 21, 2025 | Sullivan Timothy Eugene85 | Chief Financial Officer | Sale+OE | 10,000 | $28.03 | $280,300.00 | -8.3% | -27.7% | - | |
| Oct 16, 2025 | Watson David O.70 | General Counsel | Sell | 5,000 | $25.22 | $126,100.00 | -4.2% | -15.8% | - | |
| Oct 10, 2025 | Dunlop A. Sinclair62 | Director | Sell | 31,092 | $23.72 | $737,536.44 | -89.0% | +4.5% | - | |
| Sep 30, 2025 | Dunlop A. Sinclair62 | Director | Sell | 31,092 | $22.58 | $702,057.36 | -47.8% | +11.2% | - | |
| Sep 19, 2025 | Dunlop A. Sinclair62 | Director | Sell | 31,092 | $22.95 | $713,561.40 | -31.1% | +6.4% | - | |
| Sep 16, 2025 | Watson David O.70 | General Counsel | Sell | 5,000 | $24.34 | $121,700.00 | -4.0% | +3.1% | - | |
| Sep 15, 2025 | Chopas James George80 | Vp/ Chief Accounting Officer | Sell | 189 | $24.19 | $4,572.29 | -0.4% | +0.7% | - | |
| Sep 10, 2025 | Watson David O.70 | General Counsel | Sell | 20,000 | $26.17 | $523,400.00 | -28.5% | -8.7% | - | |
| Sep 8, 2025 | Sullivan Timothy Eugene85 | Chief Financial Officer | Sale+OE | 42,729 | $27.85 | $1,190,129.94 | -20.0% | -11.6% | - |